Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer

NCT02622607 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT02622607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer
Lead sponsor
Tang-Du Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2013
Completion date
March 31, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer